2026-11-13

The 9-Step Excipient Order Checklist I Use Before Signing Any Pharma PO

A practical checklist for B2B buyers sourcing pharma-grade excipients, including Ingredion products and Ingredion pharma solutions. Covers pharmacopeial grades, starch storage conditions, CCIT expectations, catalyst residue checks, and the change-notification clause most buyers skip.

By Dalia El-Masri

Who this checklist is for

If you're the buyer or supply chain lead approving pharma-grade excipient orders—specialty starches, sweeteners, buffers, the supporting chemicals that go into a formulation—this is for you. You've got a supplier quote, a COA (maybe), and a PO waiting for your signature. You have about 15 minutes to decide whether to sign or send it back.

I've been handling these orders for nine years. I've personally made and documented a dozen significant mistakes, totaling roughly $4,200 in scrap, relabeling, and rush fees. The checklist below is the one I actually use now. Nine steps. It's written with Ingredion products and Ingredion pharma solutions in mind, because that's what most of my recent work involves, but the logic applies to any excipient supplier.

The checklist

1. Confirm the pharmacopeial grade matches the destination market

Pharmacopeial grade isn't universal. 'Pharma grade' on a quote can mean USP/NF in the US, Ph. Eur. in the EU, JP in Japan—and the specs aren't identical. Before you look at price, confirm three things: the grade your customer's market requires, the edition/year of the monograph, and whether the supplier's COA references the same edition.

I learned this in 2018 when a shipment cleared USP but the customer's EU site needed Ph. Eur. The material was fine. The paperwork wasn't. That one cost us a week and about $600 in relabeling.

2. Read the COA against your approved spec, not the sales sheet

Your approved specification is the standard. The COA is the supplier's claim. Your job is to compare them line by line—moisture, microbial limits, endotoxin where applicable, particle size distribution, heavy metals. If a value is 'typical' rather than 'spec,' treat that as a red flag.

When I compared our Q1 and Q2 supplier scorecards side by side—same vendor, different spec revisions—I finally understood why the details matter so much. The summary looked fine. The line items told a different story.

3. Ask where the starch is stored—and verify the answer

Here's the question most buyers don't ask: where is the starch stored, and under what conditions? The USP-NF monograph for corn starch specifies tight containers in a cool, dry place. That's the floor, not the ceiling.

'Pack in tight containers. Store in a cool, dry place.' — USP-NF Corn Starch monograph

What I actually want to know: Is the warehouse temperature-controlled? Is the material segregated from odoriferous or oxidizing materials? Is there documented FIFO rotation? If the answer is 'we follow good practice,' ask for the SOP.

Dodged a bullet in 2021 when a site visit revealed that the designated starch storage area shared a wall with a solvent drum storage room. Nothing had gone wrong yet. But that's not a risk I wanted to sign off on.

4. Map the CCIT expectations before your customer asks

If the excipient is going into a sterile product, someone downstream will ask about container closure integrity. CCIT in pharma is governed by USP <1207>, which lays out a lifecycle approach—deterministic methods, probabilistic methods, and the validation expectations around both.

You're not running the CCIT. But you should know whether your material is hygroscopic, whether it's sterile-filtered downstream, and what your supplier's bioburden data looks like. These are the questions your customer's quality team will eventually ask. Better to have the answers before the audit, not after.

I'm not a microbiologist, so I can't speak to the science behind bioburden limits. What I can tell you from a procurement perspective is: get the data in the file early.

5. Pull the catalyst and residual solvent profile if the material touches API synthesis

If the material touches API synthesis—even as a processing aid—ask for the residual solvents statement and the metal catalyst profile. I've watched two procurement teams treat catalyst pharma materials like commodity chemicals because the line item looked simple. It's not simple. Catalyst residues can carry through, and the documentation burden is on you to request, not on the supplier to volunteer.

Bottom line: if 'catalyst pharma' appears anywhere in your supply chain documentation, give it its own verification step.

6. Check the certifications your customer actually buys

Certifications are only useful if your customer actually needs them. Organic, clean-label, EXCiPACT, IPEC—each one answers a different question. Purity Bio 805 organic waxy rice starch is a good example: if the customer needs organic, the certificate is the product. If they don't, you're paying for paperwork.

To be fair, some certifications open doors even when the current customer doesn't require them. But don't assume. Ask.

7. Get the change notification window in writing

This is the step most people skip. Ask: what's your notification window for formulation or process changes? Get it in writing, in the contract, not in an email.

In September 2022, a supplier changed a carrier material without flagging it. We found out at delivery. The order was $3,200. The rework and the customer conversation cost more than that. After the third rejection in Q1 2024, I created the pre-check list that became this checklist.

8. Stress-test the supply chain story, not the brochure version

Global supply chain is a genuine advantage—but ask the boring questions. Where is the material actually manufactured? What's the lead time variability over the last 12 months? What happens if the primary site goes down? A supplier with one plant and no disclosed backup is a single point of failure, no matter how good the brochure looks.

I'm not 100% sure how much of the recent lead time improvement is structural versus post-2023 normalization. Take that with a grain of salt. But the variability data is worth requesting either way.

9. Do the 5-minute read-back before you sign

Read the PO line items out loud. Quantity, unit of measure, grade, packaging, delivery window. It takes five minutes. In 2023, I caught a 10x quantity error this way—one click away from ordering ten times what we needed.

There's something satisfying about a clean approval. After all the document checks, the read-back is the moment where the order either holds together or falls apart. Five minutes of verification beats five days of correction.

Common mistakes I've made (so you don't have to)

  • Treating the COA as the spec. It's a claim, not a standard. Compare it to your approved spec.
  • Ignoring packaging. A fiber drum and a lined drum are not interchangeable for hygroscopic materials.
  • Assuming 'pharma grade' is global. It isn't. Check the monograph edition.
  • Not asking about change notification. The contract clause is worth more than the price discount.
  • Bundling catalyst materials into general chemical orders. Give them a separate line and a separate check.
  • Skipping the storage question. Where and how the starch is stored is part of the spec, even when it's not on the COA.

Bottom line

Five minutes of verification beats five days of correction. If this checklist saves you one rejected batch, it's paid for itself. This was accurate as of Q1 2025—pharmacopeial monographs and supplier certifications change, so verify current editions before you sign.

Need the supporting report or SDS package?

Ask the Ppg team for documentation tied to your region, application and selected coating family.

Download our 2025 report